IPP Bureau
Bulk Drug Park in the country :PIB
By IPP Bureau - July 27, 2022
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
Pharmaceuticals industry under Atmanirbhar Bharat programme
By IPP Bureau - July 27, 2022
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Tealium launches customer data platform for pharma
By IPP Bureau - July 27, 2022
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
By IPP Bureau - July 27, 2022
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
By IPP Bureau - July 27, 2022
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData
By IPP Bureau - July 27, 2022
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy
By IPP Bureau - July 27, 2022
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Aarti Drugs reports consolidated Q1 FY23 PAT at Rs. 34.78 Cr
By IPP Bureau - July 27, 2022
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr
By IPP Bureau - July 26, 2022
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
Krsnaa Diagnostics bags large tender in Maharashtra
By IPP Bureau - July 26, 2022
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Vikas Lifecare consolidated Q1FY23 PAT at Rs. 2.59 Cr
By IPP Bureau - July 26, 2022
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals Q1FY23 consolidated PAT at Rs. 119.28 Cr
By IPP Bureau - July 26, 2022
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
By IPP Bureau - July 26, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
Urinary incontinence 2nd biggest reason for limited mobility in elderly: Survey
By IPP Bureau - July 26, 2022
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
By IPP Bureau - July 26, 2022
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
